Literature DB >> 27835628

Herpes Simplex Virus Type 1 Shedding in Tears and Nasal and Oral Mucosa of Healthy Adults.

Meena Ramchandani1, Marlene Kong, Elizabeth Tronstein, Stacy Selke, Anna Mikhaylova, Amalia Magaret, Meei-Li Huang, Christine Johnston, Lawrence Corey, Anna Wald.   

Abstract

BACKGROUND: Herpes simplex virus type 1 (HSV-1) is prevalent worldwide and causes mucocutaneous infections of the oral area. We aimed to define the frequency and anatomic distribution of HSV-1 reactivation in the facial area in persons with a history of oral herpes.
METHODS: Eight immunocompetent HSV-1 seropositive adults were evaluated for shedding of HSV-1 from 12 separate orofacial sites (8 from oral mucosa, 2 from nose, and 2 from conjunctiva) 5 days a week and from the oral cavity 7 days a week for approximately 5 consecutive weeks by a HSV DNA PCR assay. Symptoms and lesions were recorded by participants.
RESULTS: Herpes simplex virus type 1 was detected at least from 1 site on 77 (26.5%) of 291 days. The most frequent site of shedding was the oral mucosa, with widespread shedding throughout the oral cavity. Lesional shedding rate was 36.4% (4 of 11 days with lesions), and the asymptomatic rate was 27.1% (65 of 240 nonlesional days). In individual participants, the median rate of HSV shedding by HSV PCR was 19.7% of days (range, 11%-63%).
CONCLUSIONS: Reactivation of HSV-1 on the oral mucosa is common and usually asymptomatic. However, HSV-1 is rarely found in tears and nasal mucosa. Frequent oral shedding of HSV-1 may increase the risk for transmitting the virus to both oral and genital mucosa of sexual partners.

Entities:  

Mesh:

Year:  2016        PMID: 27835628      PMCID: PMC5117635          DOI: 10.1097/OLQ.0000000000000522

Source DB:  PubMed          Journal:  Sex Transm Dis        ISSN: 0148-5717            Impact factor:   2.830


  30 in total

1.  Optimizing PCR positivity criterion for detection of herpes simplex virus DNA on skin and mucosa.

Authors:  Amalia S Magaret; Anna Wald; Meei-Li Huang; Stacy Selke; Larry Corey
Journal:  J Clin Microbiol       Date:  2007-02-28       Impact factor: 5.948

2.  Seroprevalence of herpes simplex virus types 1 and 2--United States, 1999-2010.

Authors:  Heather Bradley; Lauri E Markowitz; Theda Gibson; Geraldine M McQuillan
Journal:  J Infect Dis       Date:  2013-10-16       Impact factor: 5.226

3.  Herpes simplex virus type 1 genital herpes in young women: current trend in Northern Finland.

Authors:  Hanna Tuokko; Risto Bloigu; Veijo Hukkanen
Journal:  Sex Transm Infect       Date:  2014-01-15       Impact factor: 3.519

4.  Rapidly cleared episodes of oral and anogenital herpes simplex virus shedding in HIV-infected adults.

Authors:  Karen E Mark; Anna Wald; Amalia S Magaret; Stacy Selke; Steven Kuntz; Meei-Li Huang; Lawrence Corey
Journal:  J Acquir Immune Defic Syndr       Date:  2010-08       Impact factor: 3.731

5.  Neonatal herpes simplex virus infections in Canada: results of a 3-year national prospective study.

Authors:  Rhonda Y Kropp; Thomas Wong; Louise Cormier; Allison Ringrose; Sandra Burton; Joanne E Embree; Marc Steben
Journal:  Pediatrics       Date:  2006-06       Impact factor: 7.124

6.  Herpes simplex virus type 1 as a cause of genital herpes: impact on surveillance and prevention.

Authors:  W E Lafferty; L Downey; C Celum; A Wald
Journal:  J Infect Dis       Date:  2000-04-13       Impact factor: 5.226

7.  Virologic and immunologic evidence of multifocal genital herpes simplex virus 2 infection.

Authors:  Christine Johnston; Jia Zhu; Lichen Jing; Kerry J Laing; Christopher M McClurkan; Alexis Klock; Kurt Diem; Lei Jin; Jeffrey Stanaway; Elizabeth Tronstein; William W Kwok; Meei-Li Huang; Stacy Selke; Youyi Fong; Amalia Magaret; David M Koelle; Anna Wald; Lawrence Corey
Journal:  J Virol       Date:  2014-02-19       Impact factor: 5.103

8.  Asymptomatically shed recombinant herpes simplex virus type 1 strains detected in saliva.

Authors:  Jan Åke Liljeqvist; Petra Tunbäck; Peter Norberg
Journal:  J Gen Virol       Date:  2009-03       Impact factor: 3.891

9.  The natural history of recurrent herpes simplex labialis: implications for antiviral therapy.

Authors:  S L Spruance; J C Overall; E R Kern; G G Krueger; V Pliam; W Miller
Journal:  N Engl J Med       Date:  1977-07-14       Impact factor: 91.245

10.  Global and Regional Estimates of Prevalent and Incident Herpes Simplex Virus Type 1 Infections in 2012.

Authors:  Katharine J Looker; Amalia S Magaret; Margaret T May; Katherine M E Turner; Peter Vickerman; Sami L Gottlieb; Lori M Newman
Journal:  PLoS One       Date:  2015-10-28       Impact factor: 3.240

View more
  23 in total

1.  Herpes Simplex Virus 1 MicroRNA miR-H28 Exported to Uninfected Cells in Exosomes Restricts Cell-to-Cell Virus Spread by Inducing Gamma Interferon mRNA.

Authors:  Rongquan Huang; Jiaming Wu; Xusha Zhou; Haifang Jiang; Grace Guoying Zhou; Bernard Roizman
Journal:  J Virol       Date:  2019-10-15       Impact factor: 5.103

Review 2.  Cellulitis: A Review of Current Practice Guidelines and Differentiation from Pseudocellulitis.

Authors:  Michelle A Boettler; Benjamin H Kaffenberger; Catherine G Chung
Journal:  Am J Clin Dermatol       Date:  2021-12-13       Impact factor: 7.403

3.  Viral Genetics Modulate Orolabial Herpes Simplex Virus Type 1 Shedding in Humans.

Authors:  Meena S Ramchandani; Lichen Jing; Ronnie M Russell; Tran Tran; Kerry J Laing; Amalia S Magaret; Stacy Selke; Anqi Cheng; Meei-Li Huang; Hong Xie; Eric Strachan; Alex L Greninger; Pavitra Roychoudhury; Keith R Jerome; Anna Wald; David M Koelle
Journal:  J Infect Dis       Date:  2019-03-15       Impact factor: 5.226

4.  Diagnosis of human herpes virus 1 and 2 (HHV-1 and HHV-2): use of a synthetic standard curve for absolute quantification by real time polymerase chain reaction.

Authors:  Lyana Rodrigues Pinto Lima; Amanda Perse da Silva; Jonas Schmidt-Chanasit; Vanessa Salete de Paula
Journal:  Mem Inst Oswaldo Cruz       Date:  2017-02-16       Impact factor: 2.743

5.  Upregulation of Multiple CD8+ T Cell Exhaustion Pathways Is Associated with Recurrent Ocular Herpes Simplex Virus Type 1 Infection.

Authors:  Pierre-Grégoire Coulon; Soumyabrata Roy; Swayam Prakash; Ruchi Srivastava; Nisha Dhanushkodi; Stephanie Salazar; Cassandra Amezquita; Lan Nguyen; Hawa Vahed; Angela M Nguyen; Wasay R Warsi; Caitlin Ye; Edgar A Carlos-Cruz; Uyen T Mai; Lbachir BenMohamed
Journal:  J Immunol       Date:  2020-06-15       Impact factor: 5.426

6.  Promoting Simultaneous Onset of Viral Gene Expression Among Cells Infected with Herpes Simplex Virus-1.

Authors:  Maya Ralph; Marina Bednarchik; Enosh Tomer; Dor Rafael; Sefi Zargarian; Motti Gerlic; Oren Kobiler
Journal:  Front Microbiol       Date:  2017-11-01       Impact factor: 5.640

7.  Efficacy of Pleuran (β-Glucan from Pleurotus ostreatus) in the Management of Herpes Simplex Virus Type 1 Infection.

Authors:  Ingrid Urbancikova; Dana Hudackova; Juraj Majtan; Zuzana Rennerova; Peter Banovcin; Milos Jesenak
Journal:  Evid Based Complement Alternat Med       Date:  2020-04-13       Impact factor: 2.629

8.  Herpes simplex virus type 1 in Europe: systematic review, meta-analyses and meta-regressions.

Authors:  Wajiha Yousuf; Hania Ibrahim; Manale Harfouche; Farah Abu Hijleh; Laith Abu-Raddad
Journal:  BMJ Glob Health       Date:  2020-07

9.  Herpes simplex virus: global infection prevalence and incidence estimates, 2016.

Authors:  Charlotte James; Manale Harfouche; Nicky J Welton; Katherine Me Turner; Laith J Abu-Raddad; Sami L Gottlieb; Katharine J Looker
Journal:  Bull World Health Organ       Date:  2020-03-25       Impact factor: 9.408

Review 10.  A holistic perspective on herpes simplex virus (HSV) ecology and evolution.

Authors:  Molly M Rathbun; Moriah L Szpara
Journal:  Adv Virus Res       Date:  2021-06-26       Impact factor: 9.937

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.